Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Selonsertib in Participants With Moderate to Advanced Diabetic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of selonsertib in moderate to advanced diabetic kidney disease has completed; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease

Drugs mentioned

• Selonsertib (selonsertib)

Snippet

Sponsor: Gilead Sciences | Conditions: Diabetic Kidney Disease | Phase 2 | Status: COMPLETED | Results posted: 2022-12-21